Characteristic | All Women | Clearance | Persistence | p* |
---|---|---|---|---|
n = 298 | n = 117 | n = 118 | ||
n (%col) | n (%col) | n (%col) | ||
Age Group (Years) | ||||
 30–33 | 70 (23.5) | 31 (26.5) | 23 (19.5) | 0.19 |
 34–36 | 60 (20.1) | 25 (21.4) | 28 (23.7) | |
 37–42 | 82 (27.5) | 35 (29.9) | 28 (23.7) | |
 43–54 | 85 (28.5) | 26 (22.2) | 39 (33.0) | |
 Missing | 1 (0.3) | 0 (0.0) | 0 (0.0) | |
Age at Sexual Initiation (Years) | ||||
  < 18 | 180 (60.4) | 51 (43.6) | 42 (35.6) | 0.21 |
  ≥ 18 | 118 (39.6) | 66 (56.4) | 76 (64.4) | |
Number of Sexual Partners (Lifetime) | ||||
  ≤ 5 | 245 (82.2) | 94 (80.3) | 98 (83.1) | 0.59 |
  ≥ 6 | 53 (17.8) | 23 (19.7) | 20 (16.9) | |
Number of Sexual Partners (Last 6 Months) | ||||
  ≤ 5 | 285 (95.6) | 111 (94.8) | 113 (95.8) | 0.90 |
  ≥ 6 | 8 (2.7) | 3 (2.6) | 3 (2.5) | |
 Missing | 5 (1.7) | 3 (2.6) | 2 (1.7) | |
Number of Children | ||||
  < 5 | 230 (77.2) | 90 (76.9) | 92 (78.0) | 0.85 |
  ≥ 5 | 68 (22.8) | 27 (23.1) | 26 (22.0) | |
CD4 (per mm3) (Screening Visit) | ||||
  ≥ 500 (ref) | 146 (49.0) | 62 (53.0) | 49 (41.5) | 0.34 |
 350–499 | 64 (21.5) | 23 (19.7 | 26 (22.0) | |
 200–349 | 48 (16.1) | 17 (14.5) | 22 (18.6) | |
  < 200 | 25 (8.4) | 8 (6.8) | 15 (12.7) | |
 Missing | 15 (5.0) | 7 (6.0) | 6 (5.1) | |
On Anti-Retrovirals | ||||
 No | 3 (1.0) | 1 (0.9) | 2 (1.7) | 1.00 |
 Yes | 293 (98.3) | 115 (99.3) | 115 (97.5) | |
 Missing | 2 (0.7) | 1 (0.9) | 1 (0.9) | |
HIV Viral Loada (Screening Visit) | ||||
 Undetectable | 236 (79.2) | 91 (77.8) | 92 (80.0) | 0.04 |
 Detectable | 28 (9.4) | 9 (7.7) | 18 (15.3) | |
 Missing | 34 (11.4) | 17 (14.5) | 8 (6.8) | |
Time between Screening and Colposcopy Visits (Days) | ||||
 197–489 | 72 (24.2) | 27 (23.1) | 40 (33.9) | 0.06 |
 490–649 | 73 (24.5) | 39 (33.3) | 22 (18.6) | |
 650–820 | 74 (24.8) | 22 (18.8) | 29 (24.6) | |
 821–1161 | 73 (24.5) | 25 (21.4) | 25 (21.9) | |
 Missing | 6 (2.0) | 4 (3.4) | 2 (1.7) | |
VIA Result (Screening Visit) | ||||
 Negative | 228 (76.5) | 100 (85.5) | 104 (88.1) | 0.50 |
 Positive | 68 (22.8) | 15 (12.8) | 14 (11.9) | |
 Missing | 2 (0.7) | 2 (1.7) | 0 (0.0) | |
Number of hrHPV Types (Screening Visit) | ||||
 0 | 63 (21.1) | – | – | 1.00 |
 1 | 133 (44.6) | 66 (56.4) | 67 (56.8) | |
  ≥ 2 | 102 (34.2) | 51 (43.6) | 51 (43.2) | |
Colposcopic Impression | ||||
 Low-Grade | 266 (89.3) | 111 (94.9) | 96 (81.4) | < 0.01 |
 High-Grade | 25 (8.4) | 1 (0.9) | 20 (17.0) | |
 Missing | 7 (2.4) | 5 (4.3) | 2 (1.7) |